Positive News SentimentPositive NewsNASDAQ:KIDS OrthoPediatrics (KIDS) Stock Price, News & Analysis $18.37 -0.06 (-0.33%) Closing price 04:00 PM EasternExtended Trading$18.38 +0.00 (+0.03%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About OrthoPediatrics Stock (NASDAQ:KIDS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get OrthoPediatrics alerts:Sign Up Key Stats Today's Range$18.27▼$18.8050-Day Range$14.64▼$18.5052-Week Range$14.42▼$23.70Volume119,451 shsAverage Volume163,915 shsMarket Capitalization$471.74 millionP/E RatioN/ADividend YieldN/APrice Target$24.44Consensus RatingModerate Buy Company Overview OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries. The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis. OrthoPediatrics also offers unique epiphysiodesis and guided growth devices designed to correct limb length discrepancies and angular deformities in growing children. These devices are supported by accompanying instrumentation that simplifies surgical technique and enhances procedural efficiency. OrthoPediatrics markets its products through a direct sales organization in the United States and through distributors and regional offices in Europe, Latin America and the Asia-Pacific region. The company collaborates with leading pediatric orthopedic surgeons and academic institutions to advance clinical research, refine surgical protocols and expand its product offerings. Continuous investment in R&D underpins its strategy to fill gaps in pediatric care that are often overlooked by general orthopedic manufacturers. Led by a management team with deep expertise in the orthopedic device industry, OrthoPediatrics emphasizes quality systems, regulatory compliance and physician education. The company’s global footprint and specialized focus on the pediatric segment position it as a growing participant in the niche market of children’s orthopedics, striving to improve clinical outcomes and quality of life for young patients worldwide.AI Generated. May Contain Errors. Read More OrthoPediatrics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks75th Percentile Overall ScoreKIDS MarketRank™: OrthoPediatrics scored higher than 75% of companies evaluated by MarketBeat, and ranked 178th out of 858 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingModerate Buy Consensus RatingOrthoPediatrics has received a consensus rating of Moderate Buy. The company's average rating score is 2.82, and is based on 1 strong buy rating, 8 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialOrthoPediatrics has a consensus price target of $24.44, representing about 33.1% upside from its current price of $18.37.Amount of Analyst CoverageOrthoPediatrics has only been the subject of 4 research reports in the past 90 days.Read more about OrthoPediatrics' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for OrthoPediatrics are expected to grow in the coming year, from ($1.13) to ($0.98) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OrthoPediatrics is -10.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of OrthoPediatrics is -10.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrthoPediatrics has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about OrthoPediatrics' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.09% of the float of OrthoPediatrics has been sold short.Short Interest Ratio / Days to CoverOrthoPediatrics has a short interest ratio ("days to cover") of 5.07.Change versus previous monthShort interest in OrthoPediatrics has recently decreased by 5.67%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOrthoPediatrics does not currently pay a dividend.Dividend GrowthOrthoPediatrics does not have a long track record of dividend growth. News and Social Media2.9 / 5News SentimentN/A News SentimentOrthoPediatrics has a news sentiment score of 1.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for OrthoPediatrics this week, compared to 2 articles on an average week. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, OrthoPediatrics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,003,450.00 in company stock.Percentage Held by Insiders32.70% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions69.05% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about OrthoPediatrics' insider trading history. Receive KIDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KIDS Stock News HeadlinesIs the Selloff in OrthoPediatrics Corp. (KIDS) Creating a Buying Opportunity?May 13, 2026 | finance.yahoo.comCanaccord Genuity Sticks to Its Buy Rating for OrthoPediatrics (KIDS)May 6, 2026 | theglobeandmail.comI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, Amazon, Snap, and Block have done the same. Most assume this is about AI - but investor Porter Stansberry says the real driver runs far deeper. Goldman Sachs estimates 12,400 Americans are being financially harmed every day by this shift, while others grow wealthier. Stansberry - who predicted the internet economy's rise and recommended Amazon, Qualcomm, and Texas Instruments before they were household names - is now releasing a new investigation he calls The Final Displacement.May 22 at 1:00 AM | Porter & Company (Ad)OrthoPediatrics raises 2026 revenue outlook to $263M-$267M while targeting free cash flow breakevenMay 1, 2026 | seekingalpha.comOrthoPediatrics Corp (KIDS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...May 1, 2026 | finance.yahoo.comOrthoPediatrics (KIDS) Q1 2026 Earnings TranscriptMay 1, 2026 | finance.yahoo.comOrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call TranscriptApril 30, 2026 | seekingalpha.comOrthoPediatrics Corp. Reports First Quarter 2026 Financial Results and Increases 2026 Financial GuidanceApril 30, 2026 | globenewswire.comSee More Headlines KIDS Stock Analysis - Frequently Asked Questions How have KIDS shares performed this year? OrthoPediatrics' stock was trading at $17.76 at the start of the year. Since then, KIDS shares have increased by 3.4% and is now trading at $18.37. How were OrthoPediatrics' earnings last quarter? OrthoPediatrics Corp. (NASDAQ:KIDS) posted its quarterly earnings data on Thursday, April, 30th. The company reported ($0.42) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.46) by $0.04. The company earned $59.36 million during the quarter, compared to analysts' expectations of $58.29 million. OrthoPediatrics had a negative net margin of 16.31% and a negative trailing twelve-month return on equity of 7.01%. Read the conference call transcript. When did OrthoPediatrics IPO? OrthoPediatrics (KIDS) raised $52 million in an initial public offering on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers. Who are OrthoPediatrics' major shareholders? Top institutional investors of OrthoPediatrics include Granahan Investment Management LLC (3.49%), Dimensional Fund Advisors LP (2.13%), Wasatch Advisors LP (1.30%) and Roubaix Capital LLC (1.13%). Insiders that own company stock include David R Bailey, Fred Hite, Joseph W Hauser, Gregory A Odle, Daniel J Gerritzen, Mark C Throdahl and Terry D Schlotterback. View institutional ownership trends. How do I buy shares of OrthoPediatrics? Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of OrthoPediatrics own? Based on aggregate information from My MarketBeat watchlists, some other companies that OrthoPediatrics investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and AUO (AUOTY). Company Calendar Last Earnings4/30/2026Today5/22/2026Next Earnings (Estimated)8/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (52m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 KIDS's financial health is in the Red zone, according to TradeSmith. KIDS has been in this zone for over 52 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:KIDS CIK1425450 Webwww.orthopediatrics.com Phone(574) 268-6379Fax574-269-3692Employees200Year Founded2006Price Target and Rating Average Price Target for OrthoPediatrics$24.44 High Price Target$34.00 Low Price Target$17.00 Potential Upside/Downside+33.1%Consensus RatingModerate Buy Rating Score (0-4)2.82 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)($1.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$39.65 million Net Margins-16.31% Pretax Margin-16.27% Return on Equity-7.01% Return on Assets-4.86% Debt Debt-to-Equity Ratio0.29 Current Ratio5.21 Quick Ratio2.37 Sales & Book Value Annual Sales$236.35 million Price / Sales2.00 Cash Flow$0.17 per share Price / Cash Flow111.25 Book Value$13.19 per share Price / Book1.39Miscellaneous Outstanding Shares25,680,000Free Float17,286,000Market Cap$471.74 million OptionableOptionable Beta0.99 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:KIDS) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored"Computers are about to become obsolete" - George Gilder. Here’s why.George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...Eagle Publishing | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredJune 12: Elon Musk’s “Day-One Retirement Plan.”SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredI don't think Wall Street will warn you in timeWall Street insiders move early. Everyone else finds out later. That gap gets especially dangerous during a Ch...Trend Labs | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OrthoPediatrics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OrthoPediatrics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
